Your Cart ( 1 Item )

• Imiquimod 2.5% and 3.75% for the Treatment of Actinic Keratoses: Two Phase 3,Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies
  February 2014 | Volume 13 | Issue 2 | Journal Article | 166 | Copyright © February 2014
  Neil Swanson MD,^a Christina Cognata Smith PharmD,^b Mandeep Kaur MD,^b and Gary Goldenberg MD^c
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs